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Neutrophils and T cells exist in close proximity in lymph nodes and inflamed tissues during
health and disease. They are able to form stable interactions, with profound effects on the
phenotype and function of the T cells. However, the outcome of these effects are
frequently contradictory; in some systems neutrophils suppress T cell proliferation, in
others they are activatory or present antigen directly. Published protocols modelling these
interactions in vitro do not reflect the full range of interactions found in vivo; they do not
examine how activated and naïve T cells differentially respond to neutrophils, or whether
de-granulating or resting neutrophils induce different outcomes. Here, we established a
culture protocol to ask these questions with human T cells and autologous neutrophils.
We find that resting neutrophils suppress T cell proliferation, activation and cytokine
production but that de-granulating neutrophils do not, and neutrophil-released
intracellular contents enhance proliferation. Strikingly, we also demonstrate that T cells
early in the activation process are susceptible to suppression by neutrophils, while later-
stage T cells are not, and naïve T cells do not respond at all. Our protocol therefore allows
nuanced analysis of the outcome of interaction of these cells and may explain the
contradictory results observed previously.
Keywords: neutrophils, T cells, inflammation, culture models, PD1INTRODUCTION
The ability of neutrophils to influence adaptive immune responses is now well-established. Far from
being unsophisticated, short-lived cells only involved in killing during acute infection, we now know
that neutrophils can survive for up to 5 or 6 days (1), and can orchestrate T cell responses to
infection and autoimmunity. For example, neutrophils regulate T cell responses in asthma (2, 3),
assist maturation of antigen presenting cells in models of Multiple Sclerosis (4) and alter subset
differentiation and cytokine production of tumour-infiltrating T cells (5–8).
Stable interactions between the two cells have been observed (9), with formation of an ‘immune
synapse’ which can persist for minutes (9). These interactions have profound effects on the
phenotype and function of the T cells. However, the data is confusing; in some studies
neutrophils can activate T cells, present antigen directly and enhance proliferation (10–14), while
in others neutrophils suppress proliferation and induce apoptosis (9, 15–17). The reasons behindorg March 2021 | Volume 12 | Article 6334861
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that alterations in the inflammatory milieu in each case, subtly
different neutrophil populations, or the presence of different T
cell subsets, leads to divergent outcomes; however, this has
scarcely been examined.
An extra layer of complexity is provided by the fact that not
only intact neutrophils, but also their released mediators, can
affect T cell behavior. For example, exocytosis of certain anti-
microbial and/or cytotoxic molecules such as myeloperoxidase
and arginase-1 have been shown to suppress T cell proliferation
(18–20), and we have recently shown that neutrophil-derived
cathelicidin can skew T cell differentiation towards a Th17
phenotype and promote survival (21). Furthermore, release of
neutrophil extracellular traps (NETs) can directly prime human
CD4+ T cells by reducing their activation threshold so that they
can respond to suboptimal stimulation (22). NETs have been
shown to induce Th17 responses in psoriasis (23) and promote
type 2 immunity in the lung following rhinovirus infection (3). In
HIV/SIV-infected individuals, the overproduction of NETs has
also been suggested to induce apoptosis in both CD4+ and CD8+
T cells (24). These data, together, imply that different modes of
neutrophil death may lead to different outcomes in local T cells;
again, this and the mechanisms underlying it have been
under-researched.
Of particular interest to early immune responses, it is now
evident that neutrophils and T cells co-exist in the lymph nodes
and tissues during health and disease (25–28). Neutrophils
migrate to the lymph nodes in response to different stimuli
(29) by exiting the circulation through high endothelial venules
(HEVs) (30) or via the afferent lymphatics (28). Several studies
have shown that they can be involved in lasting interactions with
other immune cells (28, 31). For example, neutrophils migrate
within lymphatic vessels and enter the draining lymph nodes in
response to microbial infection during skin inflammation, which
subsequently leads to increased lymphocyte proliferation and
enhanced adaptive immunity (28). It remains unclear whether or
not neutrophils degranulate or undergo any of the processes that
lead to the release of their intracellular mediators within the
lymph node. However, MPO has been shown to be deposited in
the lymph nodes 4 hours after OVA/LPS injection (32) and
neutrophil cytoplasts (the remnants of NETs following the
expulsion of their DNA) have been identified in the
mediastinal lymph nodes of mice in a model of allergic asthma
(2). Moreover, we have recently shown that neutrophil-derived
cathelicidin can be observed in the lymph nodes of mice
immunized with heat-killed Salmonella typhimurium (21).
It is critically important to understand the mechanisms
behind these neutrophil-T cell interactions and how they may
alter T cell function during disease, and in particular to do so
using human cells. Deciphering how lymph node-stage or tissue-
stage interactions between the two cells lead to altered T cell
responses is likewise important. However, deciphering confusing
in vivo results by performing depletion of neutrophils is difficult
as this leads to an increase in T cell-stimulatory cytokine
production (33). As a result, in vitro co-culture systems are
essential for unpicking mechanisms by which neutrophilsFrontiers in Immunology | www.frontiersin.org 2influence T cell behavior. Co-culture systems also allow us to
observe differential effects of resting, de-granulating or NETosing
neutrophils using pure populations of cells.
Previous work using such systems has cultured naïve T cells
with untouched, freshly isolated peripheral blood neutrophils,
usually in the presence of high-dose T cell activation agents.
These cultures mimic the interaction of resting neutrophils with
early-activating T cells undergoing antigen presentation by
dendritic cells in the lymph nodes.
These cultures do not however model other interactions that
occur in vivo: 1) naïve cell-cell contact in the blood, 2) interaction
of T cells with activated neutrophils or their released contents
during the circa 24 hours T cells are receiving signals in lymph
nodes (28, 34–36) or 3) contact in inflamed tissues or tumors, at
which sites the vast majority of T cells present have previously
been activated in the lymph nodes and so are not naive.
In addition, neutrophils moving into lymph nodes and tissues
during disease are often activated or releasing their contents by
de-granulation or NETosis (37). To our knowledge, no in vitro
paper has modelled the interaction of human T cells with
autologous primed neutrophils or their released contents. With
this in mind, we aimed to establish a protocol for culturing
human neutrophils and T cells. Here, we describe this protocol
and assess the impact of differing neutrophils on T cell
phenotype and function. We observe that previous
demonstrations of neutrophil suppression of T cell responses
occur when the T cells are in the early stages of activation. In
contrast, if the T cells have previously been activated and meet
the neutrophils subsequently, suppression does not occur. We
also note that resting, and primed neutrophils, and their
contents, differentially affect T cell phenotype. These findings
have important implications for understanding the interactions
of these cells in vivo.METHODS
Healthy Human Donors
Peripheral venous blood was collected from healthy adult
volunteers under ethical agreement code AMREC 20-HV-069,
which included informed written consent. All University of
Edinburgh ethical regulations were observed and overseen by
the University of Edinburgh Centre for Inflammation Research
Blood Resource Management Committee.
Blood was collected into sodium citrate and was processed
immediately or within 30 mins of blood draw.
T Cell and Neutrophil EasySep Isolation
EasySep separation kits (StemCell Technologies, T Cells: #19661,
Neutrophils: #19257) were used to isolate CD3+ T cells or
neutrophils directly from human whole blood by negative
selection, as per the manufacturer’s guidelines. Briefly, 50 ul/ml
of Isolation Cocktail and 50 ul/ml of magnetic RapidSpheres
were added and incubated at room temperature for 5 mins.
Samples were then topped up with 1X PBS and placed into an
appropriate magnet for 5 mins. The enriched cell suspension wasMarch 2021 | Volume 12 | Article 633486
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volume of RapidSpheres as used previously. Finally, the sample
was placed in the magnet for another 5 mins before the final
enriched cell suspension was collected.
Neutrophil Treatments
We assessed the impact of resting, NETotic, and primed
neutrophils, as well as neutrophil contents. Total neutrophils
were resuspended in 1X PBS at a concentration of 7.5 million/mL
before each treatment was carried out.
Resting neutrophils were untreated and cultured with T cells
immediately. To direct cells towards NETosis, neutrophils
were treated with PMA (Sigma Aldrich, #P1585) for 2.5 hours
at 37°C.
Primed neutrophils were obtained by treating the cells for 25
mins with 10 mM cytochalasin B (Merck, #C6762) and 100 nM
N-Formylmethionyl-leucyl-phenylalanine (fMLF) (Merck,
#F3506); or with 2.5ng/ml LPS (Bio Science #AV-7016-1) or
20ng/ml TNF (RnD Systems #210-TA) for 30 minutes. Cells
were then washed well before co-culture. Neutrophil contents
were obtained by freeze-thawing the cells 5 times on dry ice,
followed by high speed spin to remove cell membranes, as
described by Miles et al. (38).
All neutrophils were thoroughly washed with PBS before
being co-cultured with T cells.
Cell Culture
T cells were co-cultured with neutrophils at a 5:1 N:T ratio in
round-bottom 96 well plates, in complete medium (RPMI, 10%
fetal calf serum, 10 units/mL penicillin, 10 mg/mL streptomycin
and 2 mM L-glutamine, all supplied by Gibco, ThermoFisher
UK). To model interaction of naïve T cells and resting
neutrophils, cells were co-cultured in the absence of any
stimulation. To model the interaction of early-activating T cells
and neutrophils in the lymph node, cells were co-cultured in the
presence of aCD3/aCD28 activator (1 mL ImmunoCult activator
to 1x105 cells, StemCell, #10971), which remained in the well
throughout culture. To model interaction of late-activating T
cells with neutrophils in the inflamed tissue, T cells were first
given aCD3/aCD28 stimulation for 24 h in the form of CD3/
CD28-coated Dynabeads (1 bead:100 cells; Gibco, #11161D).
The beads were then removed with a magnet, the same donor
bled again, and fresh autologous neutrophils added as above in
fresh medium.
Proliferation Assay
In order to assess proliferation, T cells were resuspended in 1X
PBS and stained with CFSE (Invitrogen, #C34554, working
concentration: 5 mM). T cells were incubated at 37°C for 20
mins and then washed twice with an excess of media.
Proliferation analysis by dye dilution was performed by flow
cytometry following 3 days co-culture.
Flow Cytometry
Cells were stained for surface markers for 30 mins at 4°C,
protected from light. DAPI (Invitrogen, #D1306, working
concentration: 1 mg/mL) was added prior to running to assessFrontiers in Immunology | www.frontiersin.org 3viability. Samples were analyzed using a LSR Fortessa cytometer
(BD Biosciences) and FlowJo software.
Antibodies
CD4-PE/Cy7 (clone A161A1, Biolegend, #357410, lot B225074);
CD8-AF647 (clone HIT8a, Biolegend, #300918, lot B235677);
PD1-PE (clone EH12.2A7, Biolegend, #329905, lot B252642).
ELISAs
The concentration of TNFa (R&D DuoSet ELISA, #DY210), IL-
10 (R&D DuoSet ELISA, #DY217B) and IFNg (R&D DuoSet
ELISA, #DY285) in cell culture supernatants was determined by
ELISA, as per the manufacturer’s guidelines.
Statistics
All data shown are expressed as individual data points with line
at mean +/- standard error. Statistical analysis was performed
using GraphPad Prism software. Two groups were compared
with two-way paired Student’s t-tests. Multiple groups from the
same experiment were compared using a one-way analysis of
variance (ANOVA) test with a Dunnett post-test. A minimum of
three donors were used over at least 2 experiments. Details
of sample sizes and statistical analyses performed are included
in all figure legends.
Data Sharing Statement
All data are available upon request to the corresponding author
at Emily.findlay@ed.ac.ukRESULTS
Establishment of a Neutrophil – T Cell Co-
Culture System
Our protocol is shown in Figure 1. T cells and autologous
neutrophils are isolated from peripheral blood of healthy
donors within 30 minutes of blood draw, by using rapid
isolation with magnetic beads. This removes the possibility that
extended blood preparation techniques will activate neutrophils
or that the cells will begin to die. Another benefit of this
technique is that each experiment requires less than 9ml blood.
To model interaction of naïve T cells and resting neutrophils
(such as those that occur in the blood), cells are co-cultured
without stimulation for 24 hours. To model the interaction of
early-activating T cells and neutrophils in the lymph node, in the
presence of dendritic cells bearing foreign antigen, cells are co-
cultured in the presence of a low dose of aCD3/aCD28
activation cocktail. To model interaction of late-activating T
cells with neutrophils in the inflamed tissue, T cells are first given
aCD3/aCD28 stimulation for 24 hours in the form of
Dynabeads. The beads are then removed with magnets, and
fresh autologous neutrophils added. Use of an activation cocktail
in the ‘early activating’ condition avoids the use of Dynabeads in
the same well as neutrophils, which can inhibit Dynabead action
and give the false appearance of suppression (39); however, use
of Dynabeads rather than soluble activators for the ‘lateMarch 2021 | Volume 12 | Article 633486
Minns et al. Neutrophil-T Cell Co-Cultureactivation’ condition allows their complete removal with
magnets before neutrophils are added on day 1.
We assessed the impact of resting, primed, apoptotic or
NETotic neutrophils, as well as their intracellular contents
(38), on T cell phenotype. Activation of T cells could be
assessed with flow cytometry, and labelling of T cells with
CFSE allowed assessment of proliferation. Finally, supernatants
were collected for cytokine analysis.
Our protocol therefore allows analysis of many ways T cells
and neutrophils can interact during inflammatory disease. It
more closely models in vivo situations than any other currently
used. Using this protocol, we asked two questions: 1. Do naïve,
early-activating and late-activating T cells respond differently to
neutrophil contact? And 2. How do T cells respond to resting,
NETotic, or primed neutrophils or their contents?
Early- and Late-Activating T Cells
Respond Differently to Neutrophil Contact
We firstly examined the impact of neutrophil exposure on T cell
proliferation after 72 hours co-culture. Naïve T cells did not
proliferate either in the presence or absence of neutrophils
(Figure 2A). As previously demonstrated in vivo and in other
culture models (9, 17, 40, 41), neutrophils suppressed
proliferation of early-activating CD4+ (Figure 2B) and CD8+ T
cells (Figure 2C, black bars). However, this was not the case with
late-activating T cells. If the T cells had received stimulation for
24 hours before neutrophil addition, neutrophils had the
opposite effect, increasing proliferation of both subsets
although most markedly in CD4+ cells (Figures 2B, C, blue
bars). It was possible that this differential response to neutrophils
was a consequence not of the neutrophils themselves, but of
neutrophil exposure in the presence of continued stimulation. To
check this, we performed a second experiment where weFrontiers in Immunology | www.frontiersin.org 4removed the Dynabeads from the late T cells, as before, but
then added activation cocktail +/- neutrophils. In this
experiment we saw that T cells responded to neutrophils in the
same way – specifically, late-activating T cells proliferated more
following neutrophil exposure, even if antigenic stimulation was
ongoing (Figure 2D). This also confirmed that, as has been
shown previously (39), neutrophils do not suppress the action of
soluble CD3/CD28 stimulation on T cells.
Next, we examined the expression of PD1, an early marker of
T cell activation (42, 43). Naïve T cells expressed low levels of
PD1 after 24 hours in culture, and this was unchanged by
neutrophil exposure (Figures 2E–G, red symbols). Neutrophils
suppressed activation of both CD4+ and CD8+ T cells in the
early-activating cultures, with the proportion expressing PD1
reducing significantly (Figures 2F, G). In contrast, neutrophil
presence increased the frequency of PD1 expression on late-
activating CD4+ T cells (Figure 2F), and did not suppress
expression on CD8+ late-activating cells (Figure 2G).
Culture supernatants were collected to assess production of
inflammatory cytokines following 24 hours co-culture. T cell
production of TNF (Figure 2H) and IFN-g (Figure 2I) was
strikingly reduced by exposure to neutrophils, if it occurred
during the early activation process. However, when late-
activation stage T cells were incubated with neutrophils, a
reduction in cytokine production did not occur. Interestingly,
IL-10 production was not altered by neutrophil exposure (Figure
2J), suggesting pro- and anti-inflammatory cytokines are affected
differentially. In every case, the very low concentration of
cytokines produced by naïve T cells was not altered by
neutrophil exposure (and IL-10 production by naïve cells
was undetectable).
Together, this suggests that early lymph node-stage T cells
encountering neutrophils are highly susceptible to suppression ofFIGURE 1 | T cell – neutrophil co-culture system. Schematic of culture system. Rapid isolation of peripheral blood neutrophils by negative magnetic selection is
performed before autologous T cells are isolated. Cells are co-cultured at a 5: 1 Neutrophil: T cell ratio either without any stimulation (‘naïve’) or in the presence of
CD3/CD28 stimulating activation cocktail (‘early’). T cells are also cultured alone in the presence of aCD3 aCD28-coated Dynabeads. 24 hours later Dynabeads are
removed and fresh autologous neutrophils isolated. These are co-cultured without any further stimulation (‘late’).March 2021 | Volume 12 | Article 633486






FIGURE 2 | Neutrophil contact differentially affects early- and late-stage activating T cells. T cells and neutrophils were isolated from peripheral blood of healthy
human donors using negative magnetic separation, and were cultured together at a 5:1 neutrophil: T cell ratio. (A) representative flow cytometry plot and
(B–D) quantification of proliferation of CD4+ and CD8+ T cells alone and in the presence of resting neutrophils. (E–G) Following 24 hours co-culture T cell activation
was assessed by flow cytometry analysis of PD-1 and (H–J) cell culture supernatant was collected at 24 hours and cytokine production assessed by ELISA. In all
cases red symbols = naïve T cells, black = early-activating and blue = late activating. # = two samples were below the limit of detection; ## = all samples were below
the limit of detection. N values of individual donors, each of which was plated separately: (B, C) 7; (D) 3; (F, G) naïve 4, early 10 for CD4 and 7 for CD8, late 7 for
CD4 and 8 for CD8 (H) naïve 3, early 13, late 10; (I) naïve 4, early 13, late 12; (J) early 4 late 3. Data between T cells exposed to neutrophils and control T cells were
analyzed by paired t tests on raw data before conversion to percentages.Frontiers in Immunology | www.frontiersin.org March 2021 | Volume 12 | Article 6334865
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production. In contrast, late tissue-stage T cells are not
suppressed by neutrophil contact; rather, proliferation and
activation of T cells at the ‘tissue-stage’ can be enhanced by
contact with resting neutrophils.
Primed and Resting Neutrophils Induce
Opposite Responses in T Cells
Our next question was whether resting or primed neutrophils, or
their contents, differentially affected T cells. We firstly examined
the activation of T cells exposed to resting neutrophils, those
primed with cytochalasin B/fMLF, TNF or LPS, those that were
apoptotic or NETotic, or their contents. Neutrophil contents
were obtained following lysis by repeated freeze-thaw cycles,
which we consider a model of necrotic cell death (38). We used
neutrophil contents in our system to compare T cells
encountering intact neutrophils to those migrating into an area
in which neutrophils have recently died or de-granulated. In the
latter situation, we suggest that T cells are exposed to a cocktail of
intracellular neutrophil mediators in the absence of any
suppressive cell surface receptors.
The results of this are intriguing. Firstly, only resting andNETotic
neutrophils significantly suppressed activation of early-activating
CD4+ and CD8+ T cells (Figures 3A, B, black symbols). In contrast,
primed neutrophils did not suppress activation significantly.
Secondly, we observed that neutrophils primed with different
mediators have different outcomes on the T cells. While
cytochalasin B/fMLF primed cells did not alter early T cell
activation, and in fact suppressed late-stage T cell activation
(Figures 3A, B), neutrophils primed with TNF and LPS
increased activation of CD4+ T cells in particular (Figure 3A).
Although this was not a significant difference, owing to variation
between donors, the increase in activation of T cells exposed to
these primed neutrophils – and the fact that only early cells
responded in this way - is interesting.
Finally, we observed that released neutrophil contents
increased PD1 expression on late-stage CD4+ and both early-
and late-stage CD8+ T cells. Released contents were therefore the
most consistently pro-activatory condition we used.
We were interested in this, and so investigated the impact of
neutrophil contents in more detail. Surprisingly, neutrophil
contents enhanced the proliferation of CD4+ (Figure 3C) and
CD8+ (Figure 3D) T cells at both activation stages – that is, in
every condition tested. In addition, the late production of TNF
(Figure 3E) was enhanced.
Together, these data demonstrate that different neutrophils
differentially affect T cell activation and proliferation.DISCUSSION
We have developed a co-culture system which allows dissection
of the interactions between human T cells and autologous
neutrophils in a variety of inflammatory settings. Using this
system, we have observed a) that T cells which meet neutrophils
at the same time as CD3 stimulation react very differently toFrontiers in Immunology | www.frontiersin.org 6those that encounter the neutrophils later; and b) that resting,
primed, NETotic neutrophils, and their intracellular contents, all
differentially affect T cell phenotype and function. These results
support previous research showing that neutrophil influence on
adaptive immunity is sophisticated and context-dependent; they
also demonstrate the importance of carefully planning in vitro
co-culture systems to investigate observations made in vivo.
We conclude firstly that neutrophils have no impact on naïve
T cells, as might be expected for cells that meet so frequently in
the blood. Next, we show that if resting neutrophils are present
early in the T cell activation process, they strongly suppress
activation, proliferation and pro-inflammatory cytokine
production. However, later on in this process these same cells
do not suppress, and can in fact enhance activation of T cells.
This has not previously been observed. This study was focused
on developing a culture system and validating it with initial
observations, rather than mechanistic analysis, and so we do not
yet understand why these differences may occur. Current
hypotheses center on a) the potential for neutrophils to
interact with a cell surface marker on T cells which is only
expressed following initial activation; b) potential differences in
the activation threshold of T cells (early T cells might have a
lower threshold than late ‘tissue-stage’ lymphocytes and
neutrophils might provide excessive stimulation, which can
lead to inhibition); and c) interaction of neutrophils with
cytokines or other mediators released from activated T cells.
Deep phenotyping of T cells at the point of neutrophil contact
will allow the testing of these hypotheses.
We also established that while resting neutrophils suppress
early-activating T cells, if the neutrophils present are primed
with TNF, LPS or cytochalasin B/fMLF, they are not suppressive
but may in fact promote activation. This suggests a check in the
development of an adaptive response, in which neutrophil
activatory signals must have been received to promote an
inflammatory response but, in their absence, the default is
suppression. Proteomic analysis of NETotic, primed, apoptotic,
and resting neutrophils may allow determination of how they
differentially affect T cell phenotype and function.
Finally, we demonstrate that the release of neutrophils’
intracellular contents enhances proliferation of T cells and, in
particular, is strongly pro-stimulatory to CD8+ T cells. We used
these contents to model the encounter of T cells with mediators
released by neutrophils following de-granulation or necrotic cell
death in the inflamed tissue. The fact that they induce T cell
activation and proliferation has not previously been
demonstrated; however, our data supports work showing that
individual intracellular neutrophil mediators can promote T cell
differentiation and inflammatory cytokine production. For
example, lactoferrin promotes Th1 generation in concert with
BCG vaccination (44) and increases T cell cytokine production
during infection with Staphylococcus aureus (45); the neutrophil
alpha defensins induce NFkb signalling in T cells (46); and the
granule peptide cathelicidin promotes Th17 differentiation (21)
and activates CD8+ T cells (47). However, all of these
interpretations must be made in light of the fact that NETotic
neutrophils did not activate the T cells, but rather suppressed asMarch 2021 | Volume 12 | Article 633486
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FIGURE 3 | Resting and primed neutrophils, and their contents, differentially affect T cells. T cells and neutrophils were isolated from peripheral blood of healthy
human donors using negative magnetic separation, and were cultured together at a 5:1 neutrophil: T cell ratio. Activation of (A) CD4+ and (B) CD8+ T cells following
24 hours co-culture with neutrophils was assessed via quantification of PD1 expression by flow cytometry. Proliferation of (C) CD4+ and (D) CD8+ T cells was
assessed following 72 hours co-culture with contents released from neutrophils during lysing. (E) Following 24 hours culture of T cells with released contents, culture
supernatant was collected and TNF measured by ELISA. In all cases black symbols = early activating T cells, blue symbols = late activating T cells. N values of
individual donors, each of which was plated separately: (A) resting 10 early 10 late; contents 10 early 7 late; CB FMLF 14 early 9 late; TNF 5 early 4 late; LPS 4 early
4 late; NETotic 10 early 6 late. (B) resting 10 early 9 late; contents 10 early 7 late; CB FMLF 10 early 11 late; TNF 4 early 4 late; LPS 4 early 4 late; NETotic 10 early
6 late. (C) 3 early 5 late; (D) 3 early 5 late; (E) 7 early 3 late. Data between T cells exposed to neutrophils and control T cells were analyzed by paired t tests on raw
data before conversion to percentages. CB/FMLF = primed with cytochalasin B and N-Formylmethionyl-leucyl-phenylalanine.Frontiers in Immunology | www.frontiersin.org March 2021 | Volume 12 | Article 6334867
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conditions – in particular, the presence of DNA and histone
proteins – must be analysed for full interpretation of this
phenomenon. Future work will focus on understanding which
mediators in particular are responsible for our observed pro-
stimulatory effects, through mass spectrometry analysis and
mechanistic targeting of those identified.
Our results are intriguing in that they show that CD4+ T cells
react more consistently to neutrophil co-culture than CD8+ T
cells. Specifically, early-stage CD4+ T cells are significantly
suppressed by resting neutrophils while late-stage CD4+ cells
are activated (Figure 2F); both stages are suppressed by NETotic
cells; and both stages are induced to proliferate further by
released neutrophil contents.
One type of neutrophil which we did not investigate was
apoptotic cells. Apoptotic neutrophils can directly and indirectly
modulate the adaptive immune response. For instance, DCs can
take up antigens from apoptotic neutrophils and act as professional
APCs for T cells (48). The release of epidermal growth factor by
apoptotic neutrophils is also involved in the maturation of
monocytes into DCs, subsequently promoting the activation of
anti-viral CD8+ T cells (49). Furthermore, engulfment of apoptotic
neutrophils regulates IL-23 cytokine production by phagocytes,
thereby controlling T cell-derived IL-17 production (50).
Conversely, uptake of human apoptotic neutrophils by DCs has
also been shown to impair DC co-stimulation and antigen
presentation, resulting in diminished allogeneic T cell responses
(51). Apoptotic PMN that have taken up tumor cell-released
autophagosomes display enhanced immunosuppressive functions:
they inhibit the proliferation and activation of both CD4+ and CD8+
T cells in a process requiring cell-contact and the generation of ROS
(52). In addition, human neutrophils can induce development of
regulatory T cells via apoptotic bodies (53). Extending our
observations to apoptotic neutrophils and comparing those results
to NETotic cells may help to determine the mechanistic
pathways involved.
Here we have demonstrated that neutrophils can suppress or
activate T cells in an opposite manner depending on whether the T
cells are naïve, receiving CD3 stimulation or at a later activation
stage. This both supports previous published work (which shows
neutrophil suppression) but also extends it considerably. Our
observations reveal a more sophisticated T cell – neutrophil
interaction than previously observed and open a new focus for
research, as lymph node and tissue (or tumour) T cells may respond
completely differently to the same neutrophil encounter.
To our knowledge, this is also the first demonstration that
neutrophil released contents have opposite outcomes on T cellFrontiers in Immunology | www.frontiersin.org 8phenotype compared to resting neutrophils. This suggests that T
cells encountering an area of neutrophil necrosis, and consequent
mediator release, will respond differently to those encountering
intact neutrophils with cell surface proteins present.
Together, our work confirms the need for nuanced culture
models which recapitulate each stage of inflammatory disease
with accuracy, and may explain why in vitro systems used
previously do not always explain observations made in vivo.DATA AVAILABILITY STATEMENT
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